title: Management of stage I testicular seminoma.
abstract: Adjuvant treatment options for stage I seminoma include surveillance, radiation, and hemotherapy. Despite excellent results for both adjuvant chemotherapy and radiotherapy, many concerns have been raised in regards to the potential long-term toxicities of these treatments. To minimize the burden of treatment, there has been a shift away from adjuvant treatments for stage I testicular seminomas toward surveillance protocols for seminoma survivors. This article reviews the evidence for all adjuvant treatment options for stage I testicular seminomas with a particular focus on surveillance.
authors.affiliation: Radiation Medicine Program, Princess Margaret Hospital, 610 University Avenue, Toronto, ON M5G 2M9, Canada.
authors.forename: Gary
authors.initials: G
authors.lastname: Mok
authors.forename: Padraig
authors.initials: P
authors.lastname: Warde
mesh_terms: D017024:Chemotherapy, Adjuvant; D003131:Combined Modality Therapy; D005500:Follow-Up Studies; D006801:Humans; D008297:Male; D009367:Neoplasm Staging; D009919:Orchiectomy; D018714:Radiotherapy, Adjuvant; D018239:Seminoma / Q000188:drug therapy / Q000532:radiotherapy / Q000601:surgery*; D013736:Testicular Neoplasms / Q000188:drug therapy / Q000532:radiotherapy / Q000601:surgery*